# Vasopressor Agents in Pulmonary Hypertension Crisis

> **NCT07667829** · NA · NOT_YET_RECRUITING · sponsor: **China National Center for Cardiovascular Diseases** · enrollment: 75 (estimated)

## Conditions studied

- Pulmonary Arterial Hypertension (PAH)
- Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
- Hypertension, Pulmonary

## Interventions

- **DRUG:** Norepinephrine
- **DRUG:** Dopamine
- **DRUG:** Epinephrine

## Key facts

- **NCT ID:** NCT07667829
- **Lead sponsor:** China National Center for Cardiovascular Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06
- **Primary completion:** 2028-12-31
- **Final completion:** 2029-01-31
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2026-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07667829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07667829, "Vasopressor Agents in Pulmonary Hypertension Crisis". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07667829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*